Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: A selective role for the 75- kilodalton receptor

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7388-7397

  Herbein, Georges ^a,b,c   Montaner, Luis J ^a   Gordon, Siamon ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; MUTANT PROTEIN; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; LONG TERMINAL REPEAT; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0029795271     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7388-7397.1996     Document Type: Article

References (65)

1. Amegllo, F., M. R. Capobianchi, C. Castilletti, P. C. Fei, S. Fais, E. Trento, and F. Dianzani. 1994. Recombinant gp120 induces IL10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines. Clin. Exp. Immunol. 95:455-458.
2. Asjo, B., I. Ivhed, M. Gidlund, S. Fuerstenberg, F. M. Fenyo, K. Nilsson, and H. Wigzell. 1987. Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones. Virology 157:359-365.
3. Biswas, P., G. Poli, A. L. Kinter, J. S. Justement, S. K. Stanley, W. J. Maury, P. J. M. Bressler, J. M. Orenstein, and A. S. Fauci. 1992. Interferon γ modulates the expression of human immunodeficiency virus in persistently infected promonocytic cells by redirecting the production of virions to intracytoplasmic vacuoles. J. Exp. Med. 176:739-750.
4. Butera, S. T., B. D. Roberts, K. Leung, G. J. Nabel, and T. M. Folks. 1993. Tumor necrosis factor receptor expression and signal transduction in HIV-1 infected cells. AIDS 7:911-918.
5. Clerici, M., and G. M. Shearer. 1993. Th1-Th2 switch is a critical step in the etiology of HIV infection, Immunol. Today 14:107-111.
6. Clouse, K. A., D. Powell, I. Washington, G. Poli, K. Strebel, W. Farrar, P. Barstad, J. Kovacs, A. S. Fauci, and T. M. Folks. 1989. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J. Immunol. 142:431-438.
7. Collin, M., and S. Gordon. 1994. The kinetics of human immunodeficiency virus reverse transcription are slower in primary human macrophages than in a lymphoid cell line. Virology 200:114-120.
8. Collin, M., G. Herbein, L. J. Montaner, and S. Gordon. 1993. PCR analysis of HIV-1 infection of macrophages: virus entry is CD4 dependent. Res. Virol. 144:13-19.
9. Duh, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1989. Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974-5978.
10. Engelmann, H., H. Holtmann, C. Brakebush, Y. S. Avni, I. Sarov, Y. Nophar, E. Hadas, O. Leitner, and D. Wallach. 1990. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265:14497-14504.
11. Espevik, T., M. Brockhaus, H. Loetscher, U. Nonstad, and R. Shalaby. 1990. Characterization of binding and biological effects of monoclonal antibodies against human tumor necrosis factor receptor. J. Exp. Med. 171:415-426.
12. Fauci, A. S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011-1018.
13. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872-877.
14. Francis, M. L., and M. S. Meltzer. 1993. Induction of IFN by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication. J. Immunol. 151:2208-2216.
15. Gehr, G., R. Gentz, M. Brockaus, H. Loetscher, and W. Lesslauer. 1992. Both tumor necrosis factor receptors mediate proliferative signals in human mononuclear cell activation. J. Immunol. 149:911-917.
16. Gessani, S., P. Puddu, B. Varano, P. Borghi, L. Conti, L. Fantuzzi, and F. Belardelli. 1994. Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in the restriction of virus replication. J. Virol. 68:1983-1986.
17. Havell, E. A. 1989. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 143:2894-2901.
18. Herbein, G., A. G. Doyle, L. J. Montaner, and S. Gordon. 1995. Lipopolysaccharide downregulates CD4 expression in primary human macrophages through induction of endogenous tumor necrosis factor and interleukin-1β. Clin. Exp. Immunol. 102:430-437.
19. Herbein, G., and S. Gordon. Unpublished data.
20. Herbein, G., S. Keshav, M. Collin, L. J. Montaner, and S. Gordon. 1994. HIV-1 induces tumor necrosis factor and interleukin-1 gene expression in primary human macrophages independent of productive infection. Clin. Exp. Immunol. 95:442-449.
21. Ivey-Hoyle, M., J. S. Culp, M. A. Chaikin, B. D. Hellmig, T. J. Matthews, R. W. Sweet, and M. Rosenberg. 1991. Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4. Proc. Natl. Acad. Sci. USA 88:512-516.
22. Jacobsen, F. W., M. Rothe, L. Rusten, D. V. Goeddel, E. B. Smeland, O. P. Veiby, L. Slordali, and S. E. W. Jacobsen. 1994. Role of the 75-kDa tumor necrosis factor (TNF) receptor: inhibition of early hematopoiesis. Proc. Natl. Acad. Sci. USA 91:10695-10699.
23. Karsten, V., S. Gordon, A. Kirn, and G. Herbein. 1996. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-α. Immunology 88:55-60.
24. Kikukawa, R., Y. Koyanagi, S. Harada, N. Kobayashi, H. Hatanaka, and N. Yamamoto. 1986. Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt 4. J. Virol. 57:1159-1162.
25. Kornbluth, R. S., P. S. Oh, J. R. Munis, P. H. Cleveland, and D. D. Richman. 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169:1137-1151.
26. Kruppa, G., B. Thoma, T. Machleidt, K. Wiegmann, and M. Kronke. 1992. Inhibition of tumor necrosis factor (TNF)-mediated NF-kappa B activation by selective blockade of the human 55-kDa TNF receptor. J. Immunol. 148:3152-3157.
27. Ladhevirta, J., C. P. J. Maury, A. M. Teppo, and H. Pepo. 1988. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85:289-291.
28. Lathey, J. L., S. Kanangat, and B. T. Rouse. 1994. Differential expression of tumor necrosis factor α and interleukin-1β compared with interleukin 6 in monocytes from human immunodeficiency virus-positive individuals measured by polymerase chain reaction. AIDS 7:109-115.
29. Loetscher, H., Y. C. E. Pan, H. W. Lahm, R. Gentz, M. Brockhaus, H. Tabuchi, and W. Lesslauer. 1990. Molecular cloning and expression of the human 55 kD tumor necrosis factor receptor. Cell 61:351-359.
30. Loetscher, H., D. Stueber, D. Banner, F. Mackay, and W. Lesslauer. 1993. Human tumor necrosis factor a (TNFα) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J. Biol. Chem. 268:26350-26357.
31. Macchia, D., F. Almerigogna, P. Parronchi, A. Ravina, E. Maggi, and S. Romagnani. 1993 Membrane tumour necrosis a is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature (London) 363:464-466.
32. Mackay, F., H. Loetscher, G. Gehr, D. Stueber, and W. Lesslauer. 1993. Tumor necrosis factor α (TNFα)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med. 177:1277-1286.
33. Mellors, J. W., B. P. Griffith, M. A. Ortiz, M. L. Landry, and J. L. Ryan. 1991. Tumor necrosis factor alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J. Infect. Dis. 163:78-82.
34. Merrill, J. E., Y. Koyanagi, and I. S. Y. Chen. 1989. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J. Virol. 63:4404-4408.
35. Mestan, J., W. Digel, S. Mittnacht, H. Hillen, D. Blohm, A. Moller, H. Jacobsen, and H. Kirchner. 1986. Antiviral effects of recombinant tumor necrosis factor in vitro. Nature (London) 323:816-819.
36. Meylan, P. R. A., J. C. Guatelli, J. R. Munis, D. D. Richman, and R. S. Kornbluth. 1993. Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages. Virology 193:138-148.
37. Miller, M. D., M. T. Warmerdam, K. A. Page, M. B. Feinberg, and W. C. Green. 1995. Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J. Virol. 69:579-584.
38. Montaner, L. J., P. Griffin, and S. Gordon. 1994. Interleukin 10 inhibits initial reverse transcription of HIV-1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro. J. Gen. Virol. 75:3393-3400.
39. Montaner, L. J., G. Herbein, and S. Gordon. Unpublished data.
40. O'Brien, W. A., A. Namazi, H. Kalhor, S. H. Mao, J. A. Zack, and I. S. Y. Chen. 1994. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol. 68:1258-1263.
41. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor α and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86:2336-2340.
42. Pauwels, R., J. Balzarini, M. Baba, R. Schnoeck, D. Schols, P. Herdewijn, J. Desmyter, and E. DeClerq. 1988. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20:309-321.
43. Pavic, I., B. Polic, I. Crnkovic, P. Lucin, S. Jonjic, and U. H. Koszinowski. 1993. Participation of endogenous tumour necrosis factor a in host resistance to cytomegalovirus infection. J. Gen. Virol. 74:2215-2223.
44. Poli, G., and A. S. Fauci. 1992. The role of monocyte/macrophages and cytokines in the pathogenesis of HIV infection. Pathobiology 60:246-251.
45. Poli, G., A. L. Kinter, and A. S. Fauci. 1994. Interleukin-1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA 91:108-112.
46. Poli, G., A. Kinter, J. S. Justement, J. H. Kehrl, P. Bressler, S. Stanley, and A. S. Fauci. 1990. Tumor necrosis factor a functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. USA 87:782-785.
47. Rimaniol, A. C., F. Boussin, A. Herbelin, D. De Groote, D. Dormont, J. F. Bach, B. Descamps-Latscha, and F. Zavala. 1994. Induction of soluble tumor necrosis factor receptor (sTNF-R75) release by HIV adsorption on cultured human monocytes. Eur. J. Immunol. 24:2055-2060.
48. Rossol-Voth, R., S. Rossol, K. H. Schutt, S. Corridori, W. Desian, and D. Falke. 1991. In vitro protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J. Gen. Virol. 72: 143-147.
49. Rothe, J., W. Lesslauer, H. Loetscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediatcd toxicity but highly susceptible to infection by Listeria monocytogenes. Nature (London) 364:798-802.
50. Rothe, J., F. Mackay, H. Bluethmann, R. Zinkernagel, and W. Lesslauer. 1994. Phenotypic analysis of TNFR1-deficient mice and characterization of TNFR1-deficient fibroblasts in vitro. Circ. Shock 44:51-56.
51. Rothe, M., S. C. Wong, W. J. Henzel, and D. V. Goeddel. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75-kDa tumor necrosis factor receptor. Cell 78:681-692.
52. Shalaby, M. R., A. Sundan, H. Loetscher, M. Brockhaus, W. Lesslauer, and T. Espevik. 1990. Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J. Exp. Med. 172:1517-1520.
53. Shambi, S. K., M. R. J. Kohonen-Corish, and I. A. Ramshaw. 1991. Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc. Natl. Acad. Sci. USA 88:4025-4029.
54. Siegel, S. A., D. J. Shealy, M. T. Nakada, J. M. Le, D. S. Wolfe, L. Probert, G. Kollias, J. Ghrayeb, J. Vilcek, and P. E. Daddona. 1995. The mouse/human chimeric monoclonal antibody cA2 neutralizes tumor necrosis factor in vitro and protects transgenic mice from cachexia and tumor necrosis factor lethality in vivo. Cytokine 7:15-25.
55. Simmonds, P., P. Balfe, J. F. Peutherer, C. A. Ludlam, J. O. Bishop, and A. J. L. Brown. 1990. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J. Virol. 64:864-872.
56. Srivasla, K. K., R. Fernandez-Larsson, D. H. Zinkus, and H. L. Robinson. 1991. Human immunodeficiency virus type 1 NL4-3 replication in four T-cell lines: rate and efficiency of entry, a major determinant of permissiveness. J. Virol. 65:3900-3902.
57. Tartaglia, L. A., and D. V. Goeddel. 1992. Two TNF receptors. Immunol. Today 13:151-153.
58. Tartaglia, L. A., D. V. Goeddel, C. Reynolds, I. S. Figari, R. F. Weber, B. M. Fendly, and M. A. Palladino. 1993. Stimulation of human T cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151:4637-4641.
59. Tartaglia, L. A., R. F. Weber, I. S. Figari, C. Reynolds, M. A. Palladino, and D. V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acacl. Sci. USA 88:9292-9296.
60. Titus, R. G., B. Sherry, and A. Cerami. 1989. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J. Exp. Med. 170:2097-2104.
61. Vandenabeele, P., W. Declercq, D. Vercammen, M. Van De Craen, J. Grooten, H. Loetscher, M. Brockhaus, W. Lesslauer, and W. Fiers. 1992. Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J. Exp. Med. 176:1015-1024.
62. Vieillard, V., E. Lauret, V. Rousseau, and E. Demayer. 1994. Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express Interferon β. Proc. Natl. Acad. Sci. USA 91:2689-2693.
63. Wong, G. H. W., and D. V. Goeddel. 1986. Tumor necrosis factor alpha and beta inhibit virus replication and synergize with interferons. Nature (London) 323:819-822.
64. Wong, G. H. W., J. F. Krowka, D. P. Stittes, and D. V. Goeddel. 1988. In vitro anti-human immunodeficiency virus activities of tumor necrosis factor alpha and interferon gamma. J. Immunol. 140:120-124.
65. Wong, G. H. W., L. A. Tartaglia, M. S. Lee, and D. V. Goeddel. 1992. Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type 1 TNF receptor. J. Immunol. 149:3350-3353.